Gastroesophageal Cancer | Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer (Companion Faculty Lecture)

Research To Practice | Oncology Videos

Featuring a slide presentation and related discussion from Dr Sunnie Kim, including the following topics:

• Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer — Dr Kim (0:00)
• Case: A man in his mid 50s with poorly differentiated mismatch repair-deficient advanced gastric cancer receives first-line nivolumab/ipilimumab (49:22)
• Case: A man in his early 70s with HER2-positive gastroesophageal junction (GEJ) adenocarcinoma who experienced disease progression on FOLFOX/trastuzumab receives trastuzumab deruxtecan (54:48)
• Case: A man in his mid 60s with Stage IV, PD-L1-positive GEJ adenocarcinoma (58:11)
• Case: A man in his early 40s with metastatic CLDN18.2-positive gastric/GEJ adenocarcinoma receives zolbetuximab (1:01:10)

CME information and select publications